Your session is about to expire
← Back to Search
Procedure
Flexible stimulation for Parkinson's Disease
N/A
Waitlist Available
Research Sponsored by University of Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up after 3 months of each intervention
Awards & highlights
No Placebo-Only Group
Summary
Exploring the benefits of the linear lead in deep brain stimulation.
Eligible Conditions
- Parkinson's Disease
- Overactive Bladder
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ after 3 months of each intervention
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~after 3 months of each intervention
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change of Overall Global functioning (PGIC)
Secondary study objectives
Cadence measured using Prokinetics gait analysis/Zeno Walkway
Change in the presence and severity of depressive symptoms using the Beck Depression Inventory (BDI)
Clinical change in motor symptoms
+6 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Flexible stimulationExperimental Treatment1 Intervention
Flexible stimulation using all available stimulation strategies provided by the VerciseTM system including stimulation of contacts 1-8 and variable pulse width and frequency.
Group II: Standard StimulationActive Control1 Intervention
Standard stimulation using contact 3-6 to achieve best therapeutic stimulation
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Deep brain stimulation
2010
Completed Phase 3
~390
Find a Location
Who is running the clinical trial?
University of TorontoLead Sponsor
714 Previous Clinical Trials
1,022,812 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger